News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
240,114 Results
Type
Article (5162)
Company Profile (19)
Press Release (234931)
Multimedia
Podcasts (4)
Webinars (4)
Section
Business (94200)
Career Advice (464)
Deals (15084)
Drug Delivery (11)
Drug Development (19173)
Employer Resources (31)
FDA (3711)
Job Trends (4155)
News (120472)
Policy (7548)
Tag
2025 Best Places to Work (4)
2026 Best Places to Work (6)
2027 BioCapital Standard (1)
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
40 Under 40 (3)
Academia (311)
Accelerated approval (15)
ADA (11)
Adcomms (4)
Allergies (27)
Alliances (14831)
ALS (65)
Alzheimer's disease (368)
Antibody-drug conjugate (ADC) (113)
Approvals (3934)
Artificial intelligence (180)
ASCO (50)
Autoimmune disease (88)
Automation (15)
Bankruptcy (97)
Belgium (17)
Best Places to Work (3105)
BIO (21)
Biologics (19)
Biosimilars (49)
BioSpace Insights (13)
Biotechnology (18)
Bispecific (9)
Bladder cancer (54)
Brain cancer (16)
Breast cancer (148)
Cancer (1431)
Cardiovascular disease (105)
Career advice (400)
Career pathing (6)
CAR-T (94)
CDC (4)
CDMO (26)
Celiac Disease (2)
Cell therapy (243)
Cervical cancer (15)
Clinical research (17562)
Collaboration (579)
Commercialization (20)
Compensation (608)
Complete response letters (15)
COVID-19 (321)
CRISPR (20)
CRO (1)
C-suite (651)
Cystic fibrosis (30)
Data (2439)
Decentralized trials (1)
Denatured (2)
Depression (28)
Dermatology (59)
Diabetes (139)
Diagnostics (2283)
Digital health (17)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (73)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (62)
Earnings (45152)
Editorial (5)
Employer branding (7)
Employer resources (34)
ESMO (63)
Events (40811)
Executive appointments (562)
Eye disease (4)
FDA (4806)
Fibrodysplasia Ossificans Progressiva (2)
Fragile X (2)
Friedreich's ataxia (10)
Frontotemporal dementia (14)
Funding (490)
Gene editing (34)
Generative AI (9)
Gene therapy (143)
GLP-1 (186)
Government (461)
Guidances (215)
Healthcare (5177)
Hematology (66)
HIV (17)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (37)
Immunology and inflammation (52)
Immuno-oncology (27)
Indications (56)
Infectious disease (367)
Inflammatory bowel disease (39)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (44)
Interviews (53)
IPO (7903)
IRA (3)
Job creations (1123)
Job search strategy (362)
JPM (4)
Kidney cancer (19)
Kidney disease (27)
Labor market (17)
Layoffs (113)
Leadership (8)
Legal (2340)
Licensing (27)
Liver cancer (26)
Longevity (8)
Lung cancer (158)
Lung diease (4)
Lymphoma (115)
Machine learning (11)
Management (10)
Manufacturing (279)
Marketing (15)
MASH (69)
Medical affairs (1)
Medical device (3974)
Medtech (4044)
Melanoma (9)
Mergers & acquisitions (7762)
Metabolic disorders (360)
mRNA (27)
Multiple sclerosis (32)
Multispecific (3)
NASH (6)
Netherlands (12)
Neurodegenerative disease (101)
Neuropsychiatric disorders (15)
Neuroscience (778)
NextGen: Class of 2026 (1675)
Non-profit (738)
Now hiring (10)
Obesity (149)
Opinion (35)
Ovarian cancer (56)
Pain (43)
Pancreatic cancer (84)
Parkinson's disease (85)
Partnered (6)
Patents (82)
Patient advocacy (2)
Patient recruitment (175)
Patient selection (15)
Peanut (6)
People (26058)
Peptides (5)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase 1 (5222)
Phase 2 (7614)
Phase 3 (6154)
Pipeline (4725)
Policy (26)
Postmarket research (625)
Preclinical (2008)
Press Release (66)
Prostate cancer (80)
Psychedelics (6)
Radiopharmaceuticals (151)
Rare diseases (291)
Real estate (1895)
Recruiting (9)
Regenerative medicine (5)
Regulatory (6028)
Reports (29)
Research institute (312)
Resumes & cover letters (69)
Rett syndrome (35)
RNA editing (3)
RSV (2)
Schizophrenia (65)
Series A (89)
Series B (73)
Series C (1)
Sickle cell disease (23)
Special edition (2)
Spinal muscular atrophy (37)
Sponsored (5)
Startups (1026)
Stem cells (2)
Stomach cancer (1)
Supply chain (26)
Switzerland (4)
Tariffs (8)
The Weekly (2)
Vaccines (112)
Venture capital (23)
Weight loss (55)
Wet AMD (2)
Women's health (17)
Worklife (1)
Date
Today (23)
Last 7 days (206)
Last 30 days (1201)
Last 365 days (9141)
2026 (8422)
2025 (9099)
2024 (11101)
2023 (13301)
2022 (18728)
2021 (19781)
2020 (18278)
2019 (13212)
2018 (10209)
2017 (10001)
2016 (9156)
2015 (12117)
2014 (9587)
2013 (7708)
2012 (8329)
2011 (8799)
2010 (8633)
Location
Africa (188)
Alabama (24)
Alaska (2)
Arizona (99)
Arkansas (2)
Asia (12138)
Australia (1762)
California (5230)
Canada (1580)
China (290)
Colorado (212)
Connecticut (255)
Delaware (102)
Europe (26708)
Florida (785)
Georgia (113)
Hawaii (1)
Idaho (24)
Illinois (249)
India (38)
Indiana (153)
Iowa (11)
Japan (316)
Kansas (52)
Kentucky (23)
Louisiana (13)
Maine (63)
Maryland (492)
Massachusetts (4367)
Michigan (116)
Minnesota (265)
Mississippi (1)
Missouri (49)
Montana (19)
Nebraska (12)
Nevada (71)
New Hampshire (16)
New Jersey (1584)
New Mexico (6)
New York (1171)
North Carolina (673)
North Dakota (7)
Northern California (2842)
Ohio (171)
Oklahoma (6)
Oregon (8)
Pennsylvania (894)
Puerto Rico (4)
Rhode Island (21)
South America (281)
South Carolina (21)
Southern California (2005)
Tennessee (93)
Texas (800)
United States (18362)
Utah (184)
Vermont (1)
Virginia (132)
Washington D.C. (18)
Washington State (469)
West Virginia (2)
Wisconsin (89)
Wyoming (2)
240,114 Results for "chromocell corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
Benuvia Operations, LLC, a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp., a pioneer in the development of non-opioid pain treatment therapeutics, are pleased to announce Chromocell’s first Development and License Agreement.
February 27, 2024
·
4 min read
Pharm Country
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
Chromocell Therapeutics Corporation today announced that its CEO Frank Knuettel, will be presenting at Alliance Global Partners Healthcare Company Showcase on Tuesday, May 21, 2024.
May 13, 2024
·
4 min read
Deals
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
Chromocell Therapeutics Corporation announced the pricing of its initial public offering of 1,100,000 shares of common stock at a public offering price of $6.00 per share.
February 16, 2024
·
3 min read
Deals
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell”, “our”, “us” or the “Company”), a clinical-stage biotech company focused on developing and commercializing new, non-opioid therapeutics to alleviate pain, today announced the closing of its initial public offering of 1,100,000 shares of its common stock at a public offering price of $6.00 per share.
February 21, 2024
·
2 min read
Business
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
Chromocell Therapeutics Corp. today announced that its interim CEO Frank Knuettel, has been appointed as the Company’s permanent CEO.
March 18, 2024
·
2 min read
Lone Star Bio
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
Chromocell Therapeutics Corp. today announced Frank Knuettel, CEO, will present and host one-on-one meetings with investors at the Sidoti March Virtual Investor Conference, taking place on March 13-14, 2024.
March 11, 2024
·
3 min read
Business
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
Chromocell Therapeutics Corp. today announced that it has formally launched its eye pain treatment program with the hiring of Dr. Simon Chandler.
March 21, 2024
·
5 min read
Press Releases
Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates
November 21, 2024
·
4 min read
Venture capital
Alphabet’s GV is one of biotech’s most influential corporate investors
The corporate investor arms of Eli Lilly, Sanofi and Pfizer have participated in billions worth of venture capital rounds, but GV is the industry’s biggest spender.
October 27, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Chromocell Announces Stock Repurchase Plan
August 7, 2024
·
5 min read
1 of 24,012
Next